7 completed, 1 withdrawn. 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 7, Withdrawn 1 |
Follow crisaborole: new trials by email Literature Review of crisaborole trials Research Report on crisaborole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo Crisaborole 2 % Topical Ointment, PF-07038124 0.01% topical ointment, NBUVB phototherapy - Vitiligo | Phase 2 | Completed | University of Colorado, Denver | 32 | 2022-09-07 | 2024-06-12 |
| Skin bioMARkers for Atopic Eczema Therapy Evaluation crisaborole (2%) ointment, betamethasone valerate 0.1% cream - Atopic Eczema/Dermatitis (Non-Specific) | Phase 2 | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 37 | 2020-11-20 | 2025-07-18 |
| Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis Dermatitis crisaborole ointment, vehicle ointment - Stasis Dermatitis | Phase 2 | Completed | Pfizer | 66 | 2020-06-26 | 2022-05-02 |
| Topical Crisaborole in Patients with Alopecia Areata Crisaborole Topical Ointment, Placebo Topical Ointment - Alopecia Areata | Phase 2 | Withdrawn | Tufts Medical Center | 2020-03-06 | 2024-10-28 | |
| Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea Crisaborole - Morphea | Phase 2 | Completed | Duke University | 8 | 2018-09-01 | 2021-04-01 |
| Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis AN2728, Placebo - Psoriasis | Phase 2 | Completed | Pfizer | 145 | 2009-11-01 | 2017-03-07 |
| Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis AN2728, Ointment vehicle - Psoriasis | Phase 2 | Completed | Pfizer | 30 | 2008-09-01 | 2017-03-06 |
| Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis AN2728, AN2728 Ointment Vehicle - Psoriasis | Phase 2 | Completed | Pfizer | 35 | 2007-11-01 | 2017-03-06 |
Psoriasis (3) · Alopecia Areata (1) · Dermatitis (1) · Dermatitis, Atopic (1) · Scleroderma, Localized (1) · Venous Insufficiency (1) · Vitiligo (1)
Pfizer (4) · Duke University (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1) · Tufts Medical Center (1) · University of Colorado, Denver (1)
United States (4) · Mexico (3) · United Kingdom (1)
Adela Cardones, MD (1) · David Rosmarin, MD (1) · Michael J Cork, MB.ChB (1) · Stanca Birlea, MD (1)
2019 (1)